Company: SNPS
Filing Date: 2025-03-03
Form Type: 424B5
Source: 0001140361-25-006661
Chunk: 12

Company: SYNOPSYS INC
Filing Date: 2025-03-03
Form: 424B5
Chunk 12
---
opsys.com and our investor relations web site is https://investors.synopsys.com. Information contained on, or accessible through, our website and our investor relations website shall not be deemed incorporated into and is not a part of this prospectus supplement, the accompanying prospectus or the registration statement of which it forms a part. We have included our website and our investor relations website in this prospectus solely as an inactive textual reference.

S-2

TABLE OF CONTENTS

Recent Developments The Ansys Merger On January 15, 2024, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) to acquire all of the outstanding shares of Ansys in a cash-and-stock transaction that values Ansys at approximately $35.0 billion, based on the closing price of Synopsys common stock on December 21, 2023. We refer to this transaction as the “Ansys Merger.” Under the terms of the Merger Agreement, at the effective time of the Ansys Merger (the “Effective Time”), each share of Ansys common stock issued and outstanding immediately prior to the Effective Time (with certain exceptions set forth in the Merger Agreement) will be converted into the right to receive 0.3450 (the “Exchange Ratio”) of a share of Synopsys common stock and $197.00 in cash, without interest. The Exchange Ratio is expected to result in Ansys equityholders and Synopsys equityholders owning approximately 16.5% and 83.5%, respectively, of the combined company on a pro forma basis following the Effective Time. The Merger Agreement also provides for Synopsys’ assumption of certain outstanding Ansys options and other unvested Ansys equity awards held by continuing Ansys employees. If the stock consideration to be issued by Synopsys in connection with the Ansys Merger would exceed 19.9999% of the shares of Synopsys common stock issued and outstanding immediately prior to the Effective Time, the Exchange Ratio will be reduced to the minimum extent necessary to ensure that the aggregate number of shares of Synopsys common stock to be issued in connection with the Ansys Merger does not exceed such threshold, and the cash consideration will be correspondingly increased to offset such adjustment. The Ansys Merger was approved by the holders of a majority of the outstanding shares of Ansys common stock on May 22, 2024 and is anticipated to close in the first half of calendar year 2025.